NASDAQ
Endonovo Therapeutics, Inc. (ENDV) has a current ratio of 0.00x as of Monday, May 25, 2026. This represents a 66.23% decrease compared to its 12-month average of 0.00x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.